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Abstract
The relationship between the growth hormone/insulin-
like growth factor (GH-IGF)-I status and memory perfor-
mance is studied in 24 elderly males and females, aged
75–85 years. Positron emission tomography (PET) was
used to measure differences in regional cerebral blood
flow during the performance of a delayed-non-match-to-
sample (DNMTS) working memory task. Quality and
speed of performance on the DNMTS task were mea-
sured separately for the easy items (3, 4 and 5 letters)
and difficult items (6, 7 and 8 letters). Results were ana-
lyzed in two different groups based on the IGF-I level of
the subjects (low or high IGF-I). Error rates on the work-
ing memory task were not different, but the high IGF-I
group had shorter reaction times on the easy items. The
high IGF-I group showed a significantly greater increase
in cerebral blood flow in the left premotor cortex (easy
items) and left dorsolateral prefrontal cortex (difficult
items) compared to the low IGF-I group. It is concluded
that elderly with high IGF-I levels are capable of faster
working memory performance and increased recruit-
ment of task-associated prefrontal regions.
Copyright © 2005 S. Karger AG, Basel
Introduction
Several factors have been identified as contributors of
cognitive decline in aging – vascular, genetic and endo-
crine factors [1–3]. Aging is accompanied by a decline in
several aspects of somatic functioning, such as a de-
creased lean body mass, reduced protein synthesis, re-
duced muscle strength, decreased bone mass and in-
creased body fat mass [4]. These features are comparable
with those of patients with growth hormone deficiency
(GHD), suggesting a mediating role for the growth hor-
mone/insulin-like growth factor I (GH-IGF-I) axis in the
process of aging.
GH stimulates the liver to secrete IGF-I and is secreted
from the anterior pituitary under the modulation of GH-
releasing hormone (GHRH) and somatostatin. GH secre-
tion and serum GH concentrations fall with age, both
baseline values and in response to provocative stimuli,
with a parallel decrease in serum concentrations of IGF-I
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[5]. IGF binding proteins (IGFBPs) are involved in the
regulation of IGF-I bioavailability, but also seem to have
their own receptors mediating IGF-I independent actions
[6].
It is known that GH may cross the blood-brain barrier
and that it is present in cerebrospinal fluid and brain tis-
sues [7]. It is also known that GH releases IGF-I in the
central nervous system. GH receptors are found in the
human brain in the choroid plexus, pituitary, hippocam-
pus, hypothalamus, putamen and thalamus [8]. Both ani-
mal and human studies show that the number of GH
receptors throughout the brain declines with age [9]. IGF-
I receptors are also found in the brain, in the hippocampal
and parahippocampal area, the amygdala, cerebellum and
prefrontal cortex [10]. In an animal study in rhesus mon-
keys, in situ hybridization showed that docking protein
p62 Dok-1 (Dok-1) mRNA was expressed in all layers of
the dorsolateral prefrontal cortex (DLPFC) and in all neu-
ronal subregions of the hippocampal formation [11].
These expression patterns are very similar to those of the
IGF-I receptor and suggest that Dok-1 could be among the
downstream targets of IGF signaling in areas of the pri-
mate brain involved in learning and memory.
IGF-I levels were found to be correlated with cognitive
function in unselected elderly subjects [12] and in healthy
centenarians [13]. A prospective study on circulating
IGF-I, IGFBP-3 and cognitive function in elderly showed
that higher total IGF-I and total IGF-I to IGFBP-3 levels
were associated with less cognitive decline over the next 2
years, as measured with the Mini Mental State Examina-
tion (MMSE) [14]. Serum IGF-I levels were associated
with mental processing speed in healthy elderly subjects
[15, 16]. These findings suggest that increasing IGF-I lev-
els in elderly subjects with low IGF-I levels may prevent
cognitive decline or even improve memory performance
or memory speed. In one study in healthy elderly subjects
the effect of growth hormone substitution (0.03 mg/kg of
body weight three times a week for a period of 6 months)
on cognitive function was investigated. An improved per-
formance on the Trail B test (a motor tracking task mea-
suring information processing, planning and cognitive
flexibility) was found, but not on the Digit Symbol Substi-
tution Test, measuring working memory, visual acuity,
cognitive flexibility and motor speed.
Scores on the MMSE and Geriatric Depression Scale
also remained unchanged [17]. A relation between GH-
IGF-I and cognition has also been found in childhood-
onset GH-deficient (CO-GHD) adults, exhibiting low GH
and IGF-I levels. These patients had significant cogni-
tive deficits compared with healthy controls, especially
with respect to memory function. CO-GHD patients per-
formed worse on an iconic memory task, a short-term
memory and a long-term memory task [18]. Growth hor-
mone replacement therapy in these patients improved
short- and long-term memory performance within 1 year
[19].
The exact mechanism behind the relation between
GH-IGF-I and memory is not known yet. To elucidate
this issue, positron emission tomography (PET) was used.
This provides the opportunity to investigate brain func-
tion in a non-invasive manner. Regional cerebral blood
flow (rCBF) was measured as an indirect marker of local
neuronal activity using oxygen-15-labeled water (H215O).
The physical half-life of 15O of 2.07 min permits repeated
measurements of rCBF during the performance of a cog-
nitive task. Data are available on PET scanning in the
field of cognition but, as far as we know, not in relation to
the GH-IGF-I axis. However, studies in rats have shown
increased cerebral blood flow as well as improved memo-
ry performance after GH and IGF-I administration [20].
The present study was aimed to investigate the neuro-
physiological substrate of working memory function in
elderly subjects with either high or low GH-IGF-I axis
activity. Working memory can be characterized as the
ability to keep a limited amount of information ‘on line’
(maintenance) for immediate use (manipulation).
Subjects performed a delayed-non-match-to-sample
(DNMTS) working memory task whilst being scanned.
This enabled the assessment of differences in memory
performance and brain activity at various memory loads.
Lesion studies in monkeys have shown that the DNMTS
task is highly dependent on the ventromedial prefrontal
cortex [21]. In humans, the DNMTS task has also been
found to activate parietal and ventrolateral prefrontal cor-
tex and, at a higher task load, DLPFC [22].
As is stated above, memory performance has been
shown to be decreased and correlated with IGF-I levels in
elderly. There is accumulating evidence that IGF-I plays
an important role in protecting neurons and participates
in neuronal growth and synaptic reorganization. As IGF-I
receptors have been localized in the frontal cortex, which
plays an important role in working memory, the protec-
tive role of IGF-I may also apply to forebrain cholinergic
neurons [23]. Based on the generally accepted knowledge
that age-related memory decline is associated with deteri-
oration of cholinergic neurons, we formulated the hypoth-
esis that working memory performance and the working
memory-associated brain activity is different in subjects
with low or high activity of the GH-IGF-I axis. It was
hypothesized that elderly subjects with high IGF-I levels
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would exhibit both a better working memory and a higher
brain activity in brain areas associated with working
memory (DLPFC and parietal cortex) than subjects with a
low GH-IGF-I status. Superior working memory would be
reflected by a better and/or faster memory performance
and increased regional brain activity as measured with
PET.
Methods
Study Population
Participants were Caucasian non-demented elderly participating
in the Longitudinal Aging Study Amsterdam (LASA). LASA investi-
gates determinants of physical, social, emotional and cognitive func-
tions in aging people in a representative stratified sample of The
Netherlands [24]. In 1,318 elderly subjects between 65 and 88 years
of age, the relationship between cognitive and emotional functions
and serum IGF-I was investigated [16]. In the present study, subjects
from the highest and lowest IGF-I quartile who met the inclusion
criteria (n = 69) were asked by telephone to participate in the present
study. Inclusion criteria were: (1) age between 70 and 85 years,
(2) MMSE score 124 (to exclude subjects with cognitive deficits) and
(3) thyroid function within the normal range. Exclusion criteria were:
(1) not being able to remain supine for at least 1 h and (2) neurologi-
cal or psychiatric disorders. A total of 24 elderly (14 males and 10
females) were included in the study. The other 45 subjects of the 69
potential subjects could not participate for different reasons, such as
poor health, fear for magnetic resonance imaging (MRI) or PET,
claustrophobia, recent hospital stay or unwillingness to be immobile
for 1 h. Education levels were defined as asking the subject for the
highest educational level completed and were ranked on a scale from
1 (elementary school not completed) to 9 (university education). All
subjects gave written informed consent. The study was approved by
the Medical Ethical Committee of the VU University Medical Cen-
ter and was conducted according to the principles of the Helsinki
Declaration.
Procedure
Participants were instructed not to use caffeine or soporific drugs
the night before and on the day of the study session and underwent
neuroimaging in the afternoon. A 30-cm3 blood sample was drawn
at noon, prior to the PET procedure to measure IGF-I, IGFBPs
and thyroid function. The blood samples were centrifuged (10 min,
3,500 rpm at 4°C) and serum was stored at –20°C until analysis.
Both the research physician and the participants were unaware
whether the subject belonged to the low or high IGF-I group.
Biochemical Data
Serum concentrations of TSH, freeT4 and freeT3 were measured
according to standardized techniques with commercially available
radioimmunoassays. Plasma IGF-I levels and IGFBP-3 levels were
measured with commercially available assays (IGF-I, Chemolum-
inescentic; Nichols Institute Diagnostics, San Juan Capistrano, Cal-
if., USA; IGFBP-3, Immunoradiometric assay; DSL, Webster, Tex.,
USA). The detection limits for IGF-I and IGFBP-3 were 6.0 nmol/l
and 0.4 mg/l, respectively. The intra-assay coefficient of variation for
IGF-I was 3% at serum IGF-I of 20 nmol/l. The inter-assay coeffi-
cients of variation were 6 and 8% at serum IGF-I of 33 and 7 nmol/l,
respectively. The normal range for IGF-I in adults, aged 161 years, is
10.3–19.0 nmol/l (P5–P95). For IGFBP-3 the intra-assay coefficient
of variation is 4% at serum IGFBP-3 of 5 mg/l and the inter-assay
coefficient of variation is 7% at serum IGFBP-3 of 3.9 mg/l. Plasma
IGFBP-4 levels were determined as described before [25]. A specific
RIA determined IGFBP-2 levels, using an antiserum that was raised
in a New Zealand rabbit against recombinant bovine IGFBP-2
(rbIGFBP-2; GroPep Ltd, Adelaide, Australia). The antiserum was
obtained after immunization with 150 Ìg of protein in incomplete
Freund’s adjuvant. The assay buffer was composed of 50 mM sodi-
um phosphate (pH 7.4), 10 mM ethylene-diamino-tetra-acetate
(EDTA), 0.05% (w/v) Tween-20, 0.2% BSA and 0.02% NaN3.
Recombinant hIGFBP-2 (GroPep Ltd) was used as a standard (range
0.02–15 ng/tube) and [125I]-rhIGFBP-2 as a tracer. Iodination of
rhIGFBP-2 was achieved following the procedure described for
IGFBP-4 [25]. The RIA incubation mixture consisted of 200 Ìl stan-
dard or diluted sample, 100 Ìl antiserum (final dilution in assay buff-
er: 1:80,000), and 100 Ìl tracer (F12,000 cpm). After equilibrium
incubation for 40–47 h at 4°C in polystyrene tubes, 100 Ìl Sac-Cel
solid-phase anti-rabbit IgG-coated cellulose suspension (Immuno-
diagnostic Systems, Boldon, UK) was added. Complexation was
complete after 30 min at room temperature, 0.5 ml distilled water
was added to the samples, which were subsequently centrifuged at
10,000 g for 4 min. Pellets were counted in a t-counter (Packard
Instrument Co., Inc., Downers Grove, Ill., USA). Intra-assay varia-
tions (10 replicates) were 8.3, 4.9 and 4.5% at mean plasma levels
of 2.4 nmol/l (73 Ìg/l), 8.2 nmol/l (256 Ìg/l) and 38.6 nmol/l
(1,205 Ìg/l), respectively. The sensitivity of the assay was 0.003
nmol/l, i.e. 0.1 Ìg/l (absolute concentration).
Neuropsychological Assessment
Mood. POMS (Profile of Mood States) [26], a self-report ques-
tionnaire, was administered in which subjects rated their feelings
over the previous 3 days. A shortened Dutch version of 32 items was
used for measuring depression, tension, fatigue, anger and vigor. The
rating (1–5) for each item was recorded. Mood scales were assessed to
control for possible group differences in task performance due to dif-
ferences in mood state.
Memory. The task performed during neuroimaging was a
DNMTS task, adapted for the PET procedure in our laboratory. This
is a working memory task specifically measuring verbal recognition
memory. During the DNMTS task a series of letters is presented on a
computer screen positioned at a distance of 0.5 m in front of the
subject. Subjects were instructed to read and remember the series of
letters and thereafter to choose the letter that they had not seen
before out of 2 letters presented on the screen. Subjects were asked to
indicate the position of the novel letter (‘non-matching’) by pressing
the compatible button of a two-button system with their right forefin-
ger (left button) or middle finger (right button). A schematic repre-
sentation of the task is shown in figure 1. Eight runs were presented
and 8 PET scans were performed, each run consisting of 3 series of
letters. Before each run, subjects were informed (on the screen)
whether the upcoming set of letters had to be remembered (activa-
tion condition) or not (baseline condition). During each run, subjects
were first presented with a series of letters for 4 s, after which the
screen was blank for a 6-second delay interval. After this delay, one of
the letters together with a novel letter appeared on the screen for 7 s,
and subjects were asked to indicate the novel letter. Thereafter the
screen was blank for 3 s followed by the second and third series of
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Fig. 1. Diagram of a baseline run (upper
panel) of the DNMTS working memory task
and an activation run (lower panel). The dif-
ferent screens were shown in succession.
Baseline runs consisted of 3 series with differ-
ent set sizes (i.e. 3, 5, 7 or 4, 6, 8 letters). Each
activation run consisted of 3 series of letters
of one set size to remember (3–8 letters) and
all the runs were presented in random order.
letters. Different set sizes were presented in random order (3, 4, 5, 6,
7, or 8 letters) in each of the six activation runs, with each run consist-
ing of only one set size. The two baseline runs each consisted of 3
series of letters of different length (i.e. 3, 5, 7 or 4, 6, 8) and the aver-
age of these 2 baseline runs provided a perceptual baseline condition,
excluding the need for memory performance. In contrast to the mem-
ory condition, the stimuli were presented continuously throughout
the 4-second familiarization period, the 6-second delay, and the 7-
second novel/target stimulus presentation. As a result, rather than
relying on memory, the subject could determine the correct answer
perceptually. Main outcomes were the number of correct responses
and reaction time (RT) in milliseconds. Task difficulty level was
defined as easy (3, 4 or 5 letters to remember) versus difficult (6, 7 or
8 letters to remember). To get acquainted with the DNMTS task,
subjects were presented with practice runs prior to the scanning ses-
sion. Subjects were instructed to perform as accurate and fast as pos-
sible within the given time limits.
Neuroimaging
PET scans were acquired using a Siemens ECAT EXACT HR+
PET scanner (CTI/Siemens, Knoxville, Tenn., USA) in 3D mode
with an axial field of view of 15 cm. Each subject underwent 8 PET
scans and for each PET scan 450 MBq of H215O was injected intrave-
nously in the antecubital vein as a bolus. Data acquisition per scan
lasted 90 s and the intervals between successive H215O injections
were approximate 9 min to allow for radioactive decay. The DNMTS
task started 20 s after the injection of the H215O bolus. Attenuation
correction was performed using a transmission scan acquired before
the emission scans. From each subject a T1-weighted structural MRI
scan was acquired using a 1.5-Tesla, Siemens Magnetom Sonata MR
scanner (MP-RAGE, magnetization prepared-rapid acquisition
gradient echo, inversion time 300 ms, TR = 15 ms, TE = 7 ms, flip
angle = 8°, voxel size 1 ! 1 ! 1.5 mm). These structural MRI scans
were acquired to rule out structural abnormalities and for overlaying
individual functional data. In addition, a mean brain image was
created for these elderly subjects allowing for correct anatomic inter-
pretation.
Image Processing
Images were reconstructed using an ordered subset-expectation
maximization (OSEM) method, with 4 iterations and 16 subsets [27,
28], followed by motion-corrected attenuation correction [29] with
the purpose to increase signal-to-noise ratio and to control for
motion-related reconstruction artifacts. PET data were analyzed
using Statistical Parametric Mapping (SPM99) software, developed
by the Functional Imaging Laboratory, London (http://www.fil.ion.
ucl.ac.uk). Images from each subject were realigned to correct for
subject movement. Thereafter the images were spatially normalized
to approximate Talairach space as defined by the SPM99 template,
and re-sampled to 3 ! 3 ! 3 mm voxel size. Data were smoothed
using a 10-mm full-width half-maximum (FWHM) Gaussian filter to
increase signal-to-noise ratio. Next, PET data were analyzed using a
linear regression model, and weighted contrasts were computed for
task versus baseline (both for easy and difficult items) across groups
as well as between groups. The main effects are reported at p ! 0.05,
corrected for multiple comparisons using the False Detection Rate
(FDR) method [30], unless indicated otherwise. Group by task inter-
actions were masked using the appropriate main effects, and are
reported at p ! 0.001 uncorrected, with a cluster size threshold of 5
voxels. Regions determined by Talairach coordinates for peak effects
were verified using anatomical localization on the mean structural
MRI created for the present study population.
Statistical Analysis
All analyses for demographic data, hormone values, mood scale
scores and task performance were carried out by means of the Statis-
tical Package for the Social Sciences (SPSS). Demographic variables
were analyzed by means of a two-sample t-test. To compare the
experimental groups with respect to the RT and accuracy of the
DNMTS, we separately analyzed the easy memory sets (by averaging
the data from 3, 4 and 5 letters) and difficult sets (by averaging the
data from 6, 7 and 8 letters). As these data appeared not to be normal-
ly distributed, analyses were performed by means of a non-paramet-
ric test, i.e. the Mann-Whitney U test. Statistical tests for the
DNMTS performance were one-tailed, based on the hypothesis that a
higher IGF-I would enhance speed of processing and quality of per-
formance. Statistical significance was set at the 0.05 level. Data are
presented as means B SD.
Results
Subject characteristics (demographic, biochemical,
and psychometric data) are shown in table 1. One patient
was excluded from analysis because of abnormalities on
the structural MRI, suggesting a previous cerebral-vascu-
lar accident. Assignment to groups was based on IGF-I
levels measured on the day of the PET scans. These IGF-I
levels were not significantly different from those mea-
sured in 1999 (data not shown, p = 0.35), on which the
selection of participants for the study was based. Only 2
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Table 1. Subject characteristics (demographic, biochemical and psy-
chometric data)
IGF low IGF high p value
Subjects 13 10
Male:female 5:8 8:2 0.05*
IGF-I, nmol/l 9.2B2.3 17.5B2.8 0.01*
IGFBP-3, mg/l 2.9B0.8 3.8B0.6 0.01*
Age, years 80.8B2.3 78.6B3.8 0.13
BMI, kg/m2 28.2B4.3 27.0B2.8 0.44
MMSE 28.5B1.6 28.6B1.2 0.95
Education level 4.6B1.3 5.5B2.1 0.25
POMS depression 11.2B5.1 10.2B3.0 0.57
POMS tension 10.2B2.7 9.9B2.8 0.83
POMS fatigue 9.1B3.8 8.7B3.6 0.81
POMS anger 11.1B6.3 10.2B2.7 0.69
POMS vigor 18.9B3.7 18.3B2.3 0.69
TSH, mU/l 1.0B0.8 1.3B1.8 0.64
Free T4, pmol/l 15.9B1.8 15.7B2.7 0.81
Free T3, pmol/l 4.4B0.7 4.7B0.7 0.35
IGFBP-2, ng/ml 506B245 404B122 0.24
IGFBP-4, ng/ml 167B40 173B32 0.68
Values are means (BSD) unless otherwise stated (* p = 0.05).
IGFBP = IGF binding protein; MMSE = Mini Mental State
Examination; POMS = Profile of Mood States.
Higher scores for POMS depression, tension fatigue and anger
reflect a negative mood; higher scores for vigor reflect a better
mood.
subjects crossed over, 1 subject from the low to the high
IGF-I group, the second the other way round. Mean age,
BMI, education level and MMSE scores were similar for
both subject groups (table 1). All participants were right-
handed, except for 1 subject in the low and 3 subjects in
the high IGF-I group who were ambidextrous. All subjects
used their right hand to press the response buttons during
the DNMTS task.
Biochemical Data
Thyroid function was within the normal range. The
groups were significantly different in IGF-I and IGFBP-3,
but not in IGFBP-2 and IGFBP-4 levels. Values are pre-
sented in table 1.
Neuropsychological Data
Regarding the performance on the DNMTS task, no
group differences were found for either the total number
of incorrect responses for easy items (3–5 letters) or for
difficult items (6–8 letters). The number of incorrect
responses during the DNMTS task for easy items was
Fig. 2. Reaction time (in seconds) for the easy (averaged 3–5 letters)
and difficult (averaged 6–8 letters) items of the DNMTS task in the
low and high IGF-I group (* p ! 0.05: low versus high IGF-I group).
Easy (3–5 letters) Difficult (6–8 letters)
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High IGF-I Low IGF-I
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0.4 B 1.2 in the low IGF-I group and 0.4 B 1.0 in the high
IGF-I group. The number of incorrect responses for diffi-
cult items was 0.9 B 1.5 in the low IGF-I group and 1.0 B
1.3 in the high IGF-I group. With respect to the RTs aver-
aged across easy items and across difficult items, we
found significantly shorter RTs only for the easy items in
the high IGF-I group (mean high IGF-I group = 1.9 B
0.7 s, mean low IGF-I group 2.3 B 0.6 s, p ! 0.04)
(fig. 2).
Imaging Data
The main effects for task (easy or difficult) versus base-
line are listed in tables 2 and 3. Across subjects, task per-
formance for easy (set size 3–5) items was associated with
increased rCBF in left superior parietal and occipital cor-
tex, and cerebellum; also at a slightly lower threshold (p !
0.1 corrected for multiple comparisons) increased rCBF
was found in the left anterior prefrontal cortex, anterior
cingulate cortex, left superior temporal cortex and bilater-
al motor cortex (fig. 3). Comparing task performance for
difficult (set size 6–8) items versus baseline, increased
rCBF was found in bilateral anterior and dorsolateral pre-
frontal cortex, left ventrolateral prefrontal cortex, as well
as anterior cingulate cortex, left superior temporal cortex,
motor cortex, right parietal cortex, occipital cortex and
cerebellum (fig. 4). The reverse contrasts (baseline 1 task,
both for easy and difficult items) did not show activations
at the chosen threshold. Task by group interactions in
favor of the high IGF-I group were identified only in left
premotor cortex for easy items, and in left DLPFC for
difficult items (table 4, fig. 5). No task by group interac-
tions in favor of the low IGF-I group were found, either
for easy items or difficult items.
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Fig. 3. Main effects of rCBF for easy items
(3–5 letters) versus baseline across high and
low IGF-I groups reported at p ! 0.05, cor-
rected for multiple comparisons using the
FDR method.
Table 2. Significant rCBF differences during performance of easy
items (3–5 letters to remember on the DNMTS task) versus baseline
across IGF-I high and low groups (n = 23)
Region Coordinates of peak voxel
X Y Z
BA Z value
Left prefrontal
anterior –27 48 12 46/10 3.75*
Anterior cingulate 9
–6
6
12
36
48
24
24
3.55*
3.42*
Left superior
temporal –63 –30 24 22 3.33*
Left superior
parietal –48 –30 57 7 4.04**
Motor/premotor 12
–57
–18
–6
60
18
6
6
3.37*
3.71*
Occipital –3
12
3
–78
–75
–81
3
6
21
18
18
18
4.98**
3.50*
4.11**
Cerebellum 3
9
–69
–45
–12
–12
4.40**
3.74*
BA = Brodmann area.
* FDR corrected p ! 0.1, cluster size threshold 5 voxels.
** FDR corrected p ! 0.05, cluster size threshold 5 voxels.
Table 3. Significant rCBF differences during performance of diffi-
cult items (6–8 letters to remember on the DNMTS task) versus base-
line across IGF-I high and low groups (n = 23)
Region Coordinates of peak voxel
X Y Z
BA Z value
Left prefrontal
Anterior
Dorsolateral
Ventrolateral
–30
–54
–69
–45
48
39
0
6
12
15
12
24
10
6/8
6
44
3.77
3.90
4.60
3.70
Right prefrontal
Anterior
Dorsolateral
36
54
42
3
18
42
46/10
9
4.69
3.75
Anterior cingulate –12
–9
12
21
27
9
42
18
36
32
24
32
5.48
3.94
3.76
Left superior
temporal –45 –36 –18 22 3.55
Right inferior
parietal 51 –39 45 40 3.43
Motor/premotor 0 6 63 6 3.40
Occipital –3
–9
–78
–81
3
12
18
18
4.47
3.70
Cerebellum 6
15
–69
–69
–15
–24
3.44
3.42
BA = Brodmann area. FDR corrected p ! 0.05, cluster size thresh-
old 5 voxels.
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Fig. 4. Main effects of rCBF for difficult
items (6–8 letters) versus baseline across
high and low IGF-I groups, reported at p !
0.05, corrected for multiple comparisons
using the FDR method.
Fig. 5. Group (high IGF-I 1 low IGF-I) by
task interaction effects shown on the created
mean brain structural MRI scan. The left
panel shows results for the easy task (3–5 let-
ters) versus baseline, the right panel shows
difficult items (6–8 letters) versus baseline.
This image shows the areas that are more
activated in subjects with high IGF-I levels
than in those with low IGF-I levels for the
easy and difficult conditions.
Table 4. Regions showing increased
activity in high IGF-I subjects compared
with low IGF-I subjects during performance
of easy (3–5 letters) and difficult items
(6–8 letters) versus baseline
Region Coordinates of peak voxel
X Y Z
BA Z value
Easy items versus baseline
Left premotor –21
–3
6
12
54
54
6
6
3.58
3.31
Difficult items versus baseline
Left dorsolateral prefrontal –27 36 30 9 3.23
p uncorrected !0.001, cluster size threshold 5 voxels. BA = Brodmann area.
4
5
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Discussion
A relationship between the GH-IGF-I axis and cogni-
tion has been demonstrated in several studies using neu-
ropsychological instruments. In the present study this
relationship was studied in elderly normal subjects per-
forming a working memory task during PET scanning.
Healthy elderly males and females were included and
based on their IGF-I level assigned to the group with the
lowest or highest IGF-I quartile. T tests indicated that
both groups had the same education level, MMSE and
mood scale scores. Error rates on the DNMTS task were
similar in both groups, indicating that the quality of work-
ing memory performance was not associated with IGF-I
level. However, there was a significant difference in RTs
on the DNMTS task between both groups. We found that
memory processing is faster in subjects with higher IGF-I
levels, but only for a small memory load. This finding is in
accordance with previous data, showing a relationship
between speed of information processing and circulating
IGF-I levels in healthy elderly [15, 16].
A post-hoc analysis on the RT data from the baseline
(perceptual) condition revealed that the high and low
IGF-I groups had similar RTs on the DNMTS task. This
indicates that both groups are not different with respect to
perceptual-motor speed. The observed differences in
speed between groups on the DNMTS task in the memory
condition therefore cannot be attributed to differences in
perceptual-motor speed, but point to a faster memory
scanning process in the high IGF-I group.
The question arises why the high IGF-I group is faster
only at a low memory load, that is the average of memory
set sizes 3, 4 and 5. These results may be seen in the light
of the reconsidered mental storage and processing capaci-
ty of 3–5 items. Instead of the magical number 7, the
magical number 4 in working memory is supported by a
large number of studies on memory capacity limits [31].
The capacity limit in working memory observed with a
wide range of procedures suggests a mean memory capac-
ity in adults of 3–5 chunks, whereas individual scores
range from about 2 to 6 chunks. In addition, both pro-
cessing and storage limits are supposed to be about 4
items each. The fundamental capacity limit coincides
with conditions in which the chunks are held in the focus
of attention, that is, the focus of attention appears to be
capacity-limited. It may be argued that the working
memory span is likely to be 4 rather than 7. Thus it may
be assumed that, especially in our elderly subjects, the
remembering of 5 or more letters is at the edge or exceed-
ing the capacity limit of working memory so that manip-
ulation of memory content by means of chunking and
memorization is needed.
The present study shows that subjects with high and
low IGF-I levels exhibit different patterns of relative
brain activation during the performance of a working
memory task. The groups, however, did not differ in the
quality of memory performance, which may be due to
ceiling effects: in spite of their highly advanced age, most
subjects found the task easy to perform and had (nearly)
perfect scores. Consequently, differences in working
memory function between both groups could only be
observed with regard to performance speed and brain
activation patterns. Thus, we can conclude that whereas
both groups show the same quality of performance, the
low IGF-I group needs more time to reach this level of
performance than the high IGF-I group.
With regard to rCBF, group differences in favor of the
high IGF-I group were found in the left premotor cortex
for easy items and left DLPFC for difficult items. As the
premotor cortex is involved in the execution of complex
behavior, the increased activity in this region may be
related to the faster working memory processing of the
high IGF-I group. The left DLPFC has been implicated in
working memory performance in previous studies, partic-
ularly at increasing memory load or when tasks require
manipulation of memory content (e.g., updating, as in the
N-back task). A correlation between increased DLPFC
activity in elderly subjects during performance of working
memory tasks and task performance has been reported
[32]. As manipulation processes are likely to occur for the
higher memory loads, exceeding working memory capaci-
ty, our results indicating a larger rCBF in left DLPFC dur-
ing higher memory loads are in line with these findings.
Across the two groups, increased task versus baseline
activity in left parietal and occipital cortex for easy items
was found, with additional activity in anterior cingulate
cortex, premotor cortex, and left prefrontal cortex. For
difficult items, more extensive, and bilateral, recruitment
of prefrontal regions was seen. Indeed, it has been pro-
posed that high-performing elderly subjects tend to re-
cruit bilateral rather than left-lateralized prefrontal net-
works during encoding of verbal material, the so-called
Hemispheric Asymmetry Reduction in Old age or
HAROLD model [33]. The involvement of parietal, dor-
solateral and ventrolateral prefrontal and anterior cingu-
late cortex in working memory is in agreement with
numerous previous studies [see 34 for a review]. Specifi-
cally, parietal cortex has been associated with phonologi-
cal storage, left ventrolateral prefrontal cortex with subvo-
cal rehearsal [35], DLPFC with manipulation of working
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memory contents [36] and anterior cingulate cortex with
attention and response selection [37].
With regard to the HAROLD model, in the present
study increased activity at higher task load was found only
in left DLPFC. At a slightly lower threshold (p = 0.0012
uncorrected), however, increased activity in right DLPFC
in high IGF-I subjects was also seen (data not shown).
Therefore, the present data indicate that high IGF-I sub-
jects were able to recruit prefrontal areas to a greater
extent during a working memory task, which was not
reflected by a higher quality of memory performance.
Apart from possible different memorization strategies as
mentioned above, it can be argued that the absence of
more pronounced cognitive differences between groups
may be due to instability of IGF-I levels over time. For the
present study, inclusion of subjects was based on IGF-I
levels measured in 1999, but group allocation was based
on pre-scan levels. There was, however, a strong correla-
tion (p = 0.002) between IGF-I levels measured in 1999
and in 2002. IGF-I serum concentrations, as a representa-
tive of GH secretion, are known to be stable during the
day [38] and in elderly there is no sex difference in IGF-I
levels. The reproducibility of IGF-I during repeated test-
ing is high [39]. To ensure that individual fluctuations in
IGF-I levels do not confound our data, we performed
post-hoc analyses of the imaging and DNMTS data of the
21 subjects with stable IGF-I values between the first
determination in 1999 and second IGF-I determination 3
years later. With respect to the imaging data, these analy-
ses yielded virtually identical results (data not shown). In
addition, our post-hoc analysis showed results for behav-
ioral data as well: subjects with low IGF-I levels were sig-
nificantly slower than those with high IGF-I levels with
respect to the easy DNMTS items (p = 0.04). There was
no difference between groups for the difficult DNMTS
items. This indicates that our results cannot be attributed
to instability of IGF-I levels.
We also investigated the possible role of gender, be-
cause the sex ratio differed between our two groups. How-
ever, analyses with sex as independent factor showed that
performance and RTs on the DNMTS were similar in
male and female subjects. In addition, post-hoc analyses
of cerebral blood flow data for the 5 male subjects in the
low IGF-I group compared with the 8 male subjects in the
high IGF-I group revealed similar results as were obtained
for all subjects (data not shown).
Finally, it should be noted that the regulation of IGF in
the central nervous system is presumably more complex
than was outlined in our Introduction, as cerebral IGF is
also involved in response to tissue damage, ischemia, etc.
We did not measure central nervous system IGF-I, but
assumed that plasma IGF-I is a good marker of cerebral
IGF-I concentration.
These data are, to the best of our knowledge, the first to
relate memory, IGF-I levels and functional differences in
brain activity. From other brain-imaging studies there is
some evidence that female sex steroid hormones modu-
late brain metabolism and blood flow both during cogni-
tive activity and baseline [see 40 for a review]. Estrogen
replacement therapy in postmenopausal women in-
creased rCBF in the temporal lobe during the resting
state. Testosterone replacement has shown to enhance
brain perfusion in the midbrain in hypogonadal men
[41].
In conclusion, this H215O PET study shows that during
a working memory task subjects with high IGF-I levels
exhibit a faster memory performance and are able to
recruit prefrontal areas to a greater extent than low IGF-I
subjects. The main finding that a difference in IGF-I level
in healthy elderly subjects can modulate rCBF activation
patterns during a working-memory task clearly needs
replication. Moreover, future studies should aim at con-
trolling subjects’ GH-IGF-I levels over time and to inves-
tigate whether an increase in IGF-I levels in low IGF-I
subjects would result in increased performance and more
extensive recruitment of prefrontal areas involved in
working memory function. This knowledge is important
in the light of counteracting negative implications of the
aging process concerning cognitive functions, which may
be related to reduced IGF-I levels.
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